AR226-2535 WASHINGTON WORKS, PARKERSBURG COMMITS ON DRAFT R O M PERMIT 1.

AR226-2559 ' 964 08/01 *01 13:01 ID:DUDUP0NTWI1" D-^085-2 302 774 6474 PAGE 2 ,. 91 07/30/01 14:03 0 :0 2 /0 6 O ;, (S > uwtkd r TM prdtecton A0BKy i'fifluitipiUs, Pwmiytva^* l a t te o K t\Jif#I11 BgfURW H tf if iin PffOCTaTgft &fo PwlIoMtttl M*nl Manag 4. diiPoni 4t>Nemciuru& Co, he aitt M2 Sautli dupontD6i| Petersburg.

RECYCLED 03 AR226-2681 3M Environmental Laboratory AR226-2681 Results from Analyses of Soil and Groundwater Samples From the E.

AR226-3065 DuPont HLR 905-96 LABORATORY FOR t o x i c o l o g y fan INDUSTRIAL MEDICINE PURPOSE: STATIC, ACUTE 48-HOUR SCREENING TEST OF H-21954 TO phnia "*9* , __j *-0 nrovid s sn estiniatfi o f This is a rangetinding stody ^ " 9;!

3M 3M Environmental Laboratory Project No.

TestAm enca TH E LEADER IN ENVIRONMENTAL TESTINO ANALYTICAL REPORT PFOA/PFOS Analysis Lot#: D7J040207 Laura Vancho/Jane Hanuszczyk NJ American W ater 213 Carriage Lane Delran, NJ 08075 TestAmerica Denver Gail DeRMzzo Project Manager October 2 2 ,2 0 0 7 \ 4955 Yarrow Street Arvada, CO B0002 tel 305.736.0100 fax 303.431.7171 www.testamerlcalnc.com NJAW0005: Table Of Contents Standard Deliverables Report Contents Standard Deliverables The Cover Letter and the Report Coverpage are considered integral parts o fthis Standard Deliverablepackage.

M 2.3.6. 0663 N-EtFOSA Pharmacokinetic - / 000475 HAZLETON WISCONSIN P O S T OFFICE B O X 7545 M A D IS O N.

/W .S i6-067S Centre Analytical Laboratories, Inc 3 04 8 Research Drive Phone: (814) 231-8032 State C ollege, PA 16801 Fax: (814) 231-1253 or (814) 231-1580 Analytical Report Fluorocheraicai Characterization of Surface Water Samples Port St.

FT,-143 Comparison Results W a s h in g to n W o rk s Q u a rte rly f 'f l ru m p lin g 1Q01 <.irnp Irl GAl IFRV RANNf Y w rsT w Eu rie tD # i GALLERY RANNtY w est w F iirin n n BV ANK IC S LCSD MS MSD notes RPR PFNA - relative percent recovery (%) for the surrogate standard perfhjorononanoic acid which is spiked m'o each sample and associated quality control sample during sample preparation for analysts LCS'LCSD * laboratory conimi sptkr/laboratory control spike duplicate rna'rt sptke/malmr spiknduplicate NA - samnle noi included tn bah h analysis r,r rrn (histon*. r-n (' ) units ug/l 399 ug/l 548 ug/L 1 58 RPR PFNA RPR PFNA RPR PFNA RPR PFNA RPR PFNA RPR PFNA RPR PFNA RPR PFNA 18 16 18 12 9 NA 16 19 oc fprnpospd TOP) 183 309 4 15 97 101 80 110 96 91 NA NA CO u lJ C O U) 00Q005 prepared for John Bowman on 5/17/01

Application Number) Application Name Candidate Substance CAS RN to be regulated Name of Candidate Substance to be regulated Generic Name of End Product for Application Generic Name of Part for Application Description of Application (Details) Drawings, Diagrams, Photographs, Videos, etc.

Ev ORE rea yy * Fr pon ON 0 Eovr --FlEunodraotpiotlsy(mEeOrLwaansytesinfEfuorcoppoelm2e0r20patos, prods and ssc vat sas en OIOY sss Main objective and conclusion (CONVERSIO & industry association pro-K): (1) Emm Minti Fema oo ar erly ka, pe ThereportFluoropolymerwastein Europe2020"wasinatedtoprovidedetaded associatedwastesteams.Th report has quabtativ and quantalivecharace.

AR226-2034 qjir5'"" IT""'^ CHAPMAGA r'" 01/09/98 09:42 AM i To: CC; Subject; MATTSORR OFFENBJL.

To whom it may concern, As a medical professional with more than 15 years of experience with PVDF-meshes for pelvic floor reconstructive surgery, I feel compelled to address the proposed restrictions on PFAS substances.